Novel adenoviral serotype 5 based immunotherapeutic induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients. (7th November 2013) - Morse, Michael; Gabitzsch, Elizabeth; Balint, Joseph P; Xu, Younong; Lyerly, HK; Jones, Frank